Skip to main content

Table 3 Predictive modelling characteristics of studies using deep learning-based fully-automated AI methods

From: Comparative performance of fully-automated and semi-automated artificial intelligence methods for the detection of clinically significant prostate cancer on MRI: a systematic review

Study

No. of patients

Training set

Validation set

Test set

Algorithm

MRI input

Image registration

Image segmentation

Outcome

Zone

Analysis

Evaluation strategy

Wang [20]

346

204

fivefold CV

142

CNN (MISN)

ADC, BVAL, DWI0, DWI1, DWI2, Ktrans,

T2WI-Cor, T2WI-Sag, T2WI-Tra

NR

Open data

csPCa vs iPCa or benign lesions

PZ or TZ

Per lesion

Internal hold-out

Fernandez-Quilez [21]

200

NRa

NRa

NRa

CNN (VGG16)

T2WI, ADC

NR

Open data

csPCa vs iPCa or benign lesions

WP

Per lesion

Internal hold-out

Schelb [22]

312

250

No

62

CNN (U-Net)

T2WI, DWI

SimpleITK, non-rigid Bspline with Mattes mutual information criterion

Automated (U-Net)

csPCa vs iPCa or benign lesions

WP

Per lesion, per patient

Internal hold-out

Deniffel [23]

499

324

75

50b

CNN (3D)

T2WI, ADC, DWI

Static, affine

Manual bounding boxes

csPCa vs iPCa or benign lesions

WP

Per patient

Internal hold-out

Seetharaman [24]

424

102

fivefold CV

322

CNN (SPCNet)

T2WI, ADC

Manual

Registration from pathology images

csPCa vs iPCa or benign lesions

WP

Per pixel, per lesion

Internal hold-out

  1. ADC, apparent diffusion coefficient; CNN, convolutional neural networks; csPCa, clinically significant prostate cancer; CV, cross-validation; DWI, diffusion-weighted imaging; iPCa, indolent prostate cancer; MISN, multi-input selection network; MRI, magnetic resonance imaging; NR, not reported; PZ, peripheral zone; T2WI, T2-weighted imaging; TZ, transition zone; WP, whole prostate
  2. aThe study included 200 patients and 299 lesions, of which 70% were used to train train, 20% to test, 10% to fine-tune the models
  3. bDescribes the calibration cohort